This was confirmed via addition of a TNF‐α small‐molecule inhibitor to osteocyte conditioned media, which significantly inhibited the decreased cancer cell proliferation and increased migration such that there were no significant differences compared to cancer cells alone (Figure8A). The gene discussed is TNF; the disease is cancer.